nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—CTSG—Activation of Matrix Metalloproteinases—TIMP2—intracranial aneurysm	0.104	0.13	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—TIMP2—intracranial aneurysm	0.0457	0.0573	CbGpPWpGaD
Bortezomib—CTSG—Activation of Matrix Metalloproteinases—CTSK—intracranial aneurysm	0.0451	0.0565	CbGpPWpGaD
Bortezomib—CTSG—Activation of Matrix Metalloproteinases—TIMP1—intracranial aneurysm	0.0342	0.0428	CbGpPWpGaD
Bortezomib—CTSG—ACE Inhibitor Pathway—NOS3—intracranial aneurysm	0.0256	0.032	CbGpPWpGaD
Bortezomib—CTSG—Regulation of IGF Activity by IGFBP—MMP2—intracranial aneurysm	0.023	0.0289	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—CTSS—intracranial aneurysm	0.0216	0.0271	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—CTSK—intracranial aneurysm	0.0199	0.0249	CbGpPWpGaD
Bortezomib—CTSG—Extracellular matrix organization—TIMP2—intracranial aneurysm	0.0192	0.024	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—CTSB—intracranial aneurysm	0.0165	0.0206	CbGpPWpGaD
Bortezomib—CTSG—Activation of Matrix Metalloproteinases—MMP2—intracranial aneurysm	0.0165	0.0206	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—TIMP1—intracranial aneurysm	0.0151	0.0189	CbGpPWpGaD
Bortezomib—CTSG—Extracellular matrix organization—ELN—intracranial aneurysm	0.0137	0.0171	CbGpPWpGaD
Bortezomib—CTSG—Activation of Matrix Metalloproteinases—MMP9—intracranial aneurysm	0.0124	0.0155	CbGpPWpGaD
Bortezomib—PSMD1—medulla oblongata—intracranial aneurysm	0.0112	0.0557	CbGeAlD
Bortezomib—PSMD1—midbrain—intracranial aneurysm	0.0103	0.0509	CbGeAlD
Bortezomib—CTSG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—intracranial aneurysm	0.00995	0.0125	CbGpPWpGaD
Bortezomib—PSMD2—medulla oblongata—intracranial aneurysm	0.00994	0.0493	CbGeAlD
Bortezomib—PSMA1—Antigen processing-Cross presentation—CTSS—intracranial aneurysm	0.00969	0.0121	CbGpPWpGaD
Bortezomib—PSMD1—Antigen processing-Cross presentation—CTSS—intracranial aneurysm	0.00964	0.0121	CbGpPWpGaD
Bortezomib—PSMD2—Antigen processing-Cross presentation—CTSS—intracranial aneurysm	0.0096	0.012	CbGpPWpGaD
Bortezomib—PSMA1—cerebellum—intracranial aneurysm	0.00945	0.0469	CbGeAlD
Bortezomib—PSMD2—midbrain—intracranial aneurysm	0.00908	0.0451	CbGeAlD
Bortezomib—CTSG—Extracellular matrix organization—CTSS—intracranial aneurysm	0.00907	0.0114	CbGpPWpGaD
Bortezomib—PSMB5—medulla oblongata—intracranial aneurysm	0.00872	0.0433	CbGeAlD
Bortezomib—CTSG—Extracellular matrix organization—CTSK—intracranial aneurysm	0.00834	0.0104	CbGpPWpGaD
Bortezomib—PSMB5—midbrain—intracranial aneurysm	0.00797	0.0396	CbGeAlD
Bortezomib—PSMD1—cerebellum—intracranial aneurysm	0.00793	0.0394	CbGeAlD
Bortezomib—PSMA1—brain—intracranial aneurysm	0.00767	0.0381	CbGeAlD
Bortezomib—PSMB1—medulla oblongata—intracranial aneurysm	0.00762	0.0378	CbGeAlD
Bortezomib—PSMB2—medulla oblongata—intracranial aneurysm	0.00744	0.0369	CbGeAlD
Bortezomib—PSMB1—Antigen processing-Cross presentation—CTSS—intracranial aneurysm	0.00734	0.00919	CbGpPWpGaD
Bortezomib—PSMB5—Antigen processing-Cross presentation—CTSS—intracranial aneurysm	0.00734	0.00919	CbGpPWpGaD
Bortezomib—PSMA1—Antigen processing-Cross presentation—NCF1—intracranial aneurysm	0.00734	0.00919	CbGpPWpGaD
Bortezomib—PSMB2—Antigen processing-Cross presentation—CTSS—intracranial aneurysm	0.00734	0.00919	CbGpPWpGaD
Bortezomib—PSMD1—Antigen processing-Cross presentation—NCF1—intracranial aneurysm	0.00731	0.00915	CbGpPWpGaD
Bortezomib—PSMD2—Antigen processing-Cross presentation—NCF1—intracranial aneurysm	0.00727	0.00911	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—MMP2—intracranial aneurysm	0.00726	0.00909	CbGpPWpGaD
Bortezomib—PSMB8—Antigen processing-Cross presentation—CTSS—intracranial aneurysm	0.00724	0.00907	CbGpPWpGaD
Bortezomib—PSMD2—cerebellum—intracranial aneurysm	0.00702	0.0349	CbGeAlD
Bortezomib—PSMB1—midbrain—intracranial aneurysm	0.00697	0.0346	CbGeAlD
Bortezomib—CTSG—Extracellular matrix organization—CTSB—intracranial aneurysm	0.00691	0.00865	CbGpPWpGaD
Bortezomib—PSMB2—midbrain—intracranial aneurysm	0.0068	0.0338	CbGeAlD
Bortezomib—PTGS1—artery—intracranial aneurysm	0.00647	0.0321	CbGeAlD
Bortezomib—SLC31A1—medulla oblongata—intracranial aneurysm	0.00644	0.032	CbGeAlD
Bortezomib—PSMD1—brain—intracranial aneurysm	0.00644	0.032	CbGeAlD
Bortezomib—CTSG—Extracellular matrix organization—TIMP1—intracranial aneurysm	0.00632	0.00792	CbGpPWpGaD
Bortezomib—PSMB5—cerebellum—intracranial aneurysm	0.00617	0.0306	CbGeAlD
Bortezomib—PTGS1—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.00602	0.00754	CbGpPWpGaD
Bortezomib—SLC31A1—midbrain—intracranial aneurysm	0.00589	0.0292	CbGeAlD
Bortezomib—PSMD2—brain—intracranial aneurysm	0.00571	0.0283	CbGeAlD
Bortezomib—PSMB8—brain—intracranial aneurysm	0.00567	0.0282	CbGeAlD
Bortezomib—PSMB2—Antigen processing-Cross presentation—NCF1—intracranial aneurysm	0.00556	0.00697	CbGpPWpGaD
Bortezomib—PSMB5—Antigen processing-Cross presentation—NCF1—intracranial aneurysm	0.00556	0.00697	CbGpPWpGaD
Bortezomib—PSMB1—Antigen processing-Cross presentation—NCF1—intracranial aneurysm	0.00556	0.00697	CbGpPWpGaD
Bortezomib—PSMB8—Antigen processing-Cross presentation—NCF1—intracranial aneurysm	0.00549	0.00687	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—MMP9—intracranial aneurysm	0.00546	0.00683	CbGpPWpGaD
Bortezomib—PSMB1—cerebellum—intracranial aneurysm	0.00539	0.0268	CbGeAlD
Bortezomib—PSMB2—cerebellum—intracranial aneurysm	0.00526	0.0261	CbGeAlD
Bortezomib—PSMB5—brain—intracranial aneurysm	0.00501	0.0249	CbGeAlD
Bortezomib—SLC31A1—cerebellum—intracranial aneurysm	0.00455	0.0226	CbGeAlD
Bortezomib—PSMB1—brain—intracranial aneurysm	0.00438	0.0217	CbGeAlD
Bortezomib—PSMB2—brain—intracranial aneurysm	0.00427	0.0212	CbGeAlD
Bortezomib—PSMA1—Class I MHC mediated antigen processing & presentation—CTSS—intracranial aneurysm	0.00387	0.00485	CbGpPWpGaD
Bortezomib—PSMD1—Class I MHC mediated antigen processing & presentation—CTSS—intracranial aneurysm	0.00385	0.00482	CbGpPWpGaD
Bortezomib—PSMD2—Class I MHC mediated antigen processing & presentation—CTSS—intracranial aneurysm	0.00383	0.0048	CbGpPWpGaD
Bortezomib—SLC31A1—brain—intracranial aneurysm	0.0037	0.0184	CbGeAlD
Bortezomib—CTSG—Extracellular matrix organization—MMP2—intracranial aneurysm	0.00304	0.00381	CbGpPWpGaD
Bortezomib—PSMD2—TNF alpha Signaling Pathway—CCL2—intracranial aneurysm	0.00303	0.00379	CbGpPWpGaD
Bortezomib—PSMA1—Cell Cycle—RBBP8—intracranial aneurysm	0.00299	0.00374	CbGpPWpGaD
Bortezomib—PSMD1—Cell Cycle—RBBP8—intracranial aneurysm	0.00297	0.00372	CbGpPWpGaD
Bortezomib—PSMD2—Cell Cycle—RBBP8—intracranial aneurysm	0.00296	0.0037	CbGpPWpGaD
Bortezomib—PSMA1—Class I MHC mediated antigen processing & presentation—NCF1—intracranial aneurysm	0.00293	0.00367	CbGpPWpGaD
Bortezomib—PSMB2—Class I MHC mediated antigen processing & presentation—CTSS—intracranial aneurysm	0.00293	0.00367	CbGpPWpGaD
Bortezomib—PSMB1—Class I MHC mediated antigen processing & presentation—CTSS—intracranial aneurysm	0.00293	0.00367	CbGpPWpGaD
Bortezomib—PSMB5—Class I MHC mediated antigen processing & presentation—CTSS—intracranial aneurysm	0.00293	0.00367	CbGpPWpGaD
Bortezomib—PSMD1—Class I MHC mediated antigen processing & presentation—NCF1—intracranial aneurysm	0.00292	0.00365	CbGpPWpGaD
Bortezomib—PSMD2—Class I MHC mediated antigen processing & presentation—NCF1—intracranial aneurysm	0.0029	0.00364	CbGpPWpGaD
Bortezomib—PSMB8—Class I MHC mediated antigen processing & presentation—CTSS—intracranial aneurysm	0.00289	0.00362	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—STARD13—intracranial aneurysm	0.00246	0.00309	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—STARD13—intracranial aneurysm	0.00245	0.00307	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—STARD13—intracranial aneurysm	0.00244	0.00306	CbGpPWpGaD
Bortezomib—PSMA1—Disease—SLC25A16—intracranial aneurysm	0.00244	0.00305	CbGpPWpGaD
Bortezomib—PSMD1—Disease—SLC25A16—intracranial aneurysm	0.00243	0.00304	CbGpPWpGaD
Bortezomib—PSMD2—Disease—SLC25A16—intracranial aneurysm	0.00242	0.00303	CbGpPWpGaD
Bortezomib—CTSG—Extracellular matrix organization—MMP9—intracranial aneurysm	0.00229	0.00286	CbGpPWpGaD
Bortezomib—CYP2D6—brainstem—intracranial aneurysm	0.00227	0.0112	CbGeAlD
Bortezomib—PSMB2—Cell Cycle—RBBP8—intracranial aneurysm	0.00226	0.00283	CbGpPWpGaD
Bortezomib—PSMB1—Cell Cycle—RBBP8—intracranial aneurysm	0.00226	0.00283	CbGpPWpGaD
Bortezomib—PSMB5—Cell Cycle—RBBP8—intracranial aneurysm	0.00226	0.00283	CbGpPWpGaD
Bortezomib—PSMB8—Cell Cycle—RBBP8—intracranial aneurysm	0.00223	0.00279	CbGpPWpGaD
Bortezomib—PSMB2—Class I MHC mediated antigen processing & presentation—NCF1—intracranial aneurysm	0.00222	0.00278	CbGpPWpGaD
Bortezomib—PSMB5—Class I MHC mediated antigen processing & presentation—NCF1—intracranial aneurysm	0.00222	0.00278	CbGpPWpGaD
Bortezomib—PSMB1—Class I MHC mediated antigen processing & presentation—NCF1—intracranial aneurysm	0.00222	0.00278	CbGpPWpGaD
Bortezomib—PSMB8—Class I MHC mediated antigen processing & presentation—NCF1—intracranial aneurysm	0.00219	0.00274	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—SLC25A16—intracranial aneurysm	0.00204	0.00256	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—SLC25A16—intracranial aneurysm	0.00203	0.00255	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—SLC25A16—intracranial aneurysm	0.00202	0.00253	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—CTSS—intracranial aneurysm	0.00192	0.0024	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—CTSS—intracranial aneurysm	0.00191	0.00239	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—CTSS—intracranial aneurysm	0.0019	0.00238	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—STARD13—intracranial aneurysm	0.00187	0.00234	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—STARD13—intracranial aneurysm	0.00187	0.00234	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—STARD13—intracranial aneurysm	0.00187	0.00234	CbGpPWpGaD
Bortezomib—PSMB2—Disease—SLC25A16—intracranial aneurysm	0.00185	0.00231	CbGpPWpGaD
Bortezomib—PSMB5—Disease—SLC25A16—intracranial aneurysm	0.00185	0.00231	CbGpPWpGaD
Bortezomib—PSMB1—Disease—SLC25A16—intracranial aneurysm	0.00185	0.00231	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—STARD13—intracranial aneurysm	0.00184	0.00231	CbGpPWpGaD
Bortezomib—PSMB8—Disease—SLC25A16—intracranial aneurysm	0.00182	0.00228	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—CTSK—intracranial aneurysm	0.00176	0.00221	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—CTSK—intracranial aneurysm	0.00175	0.0022	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—CTSK—intracranial aneurysm	0.00175	0.00219	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—SLC25A16—intracranial aneurysm	0.00155	0.00194	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—SLC25A16—intracranial aneurysm	0.00155	0.00194	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—SLC25A16—intracranial aneurysm	0.00155	0.00194	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—SLC25A16—intracranial aneurysm	0.00153	0.00191	CbGpPWpGaD
Bortezomib—CTSG—Metabolism of proteins—CCL2—intracranial aneurysm	0.00149	0.00187	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—CTSB—intracranial aneurysm	0.00146	0.00183	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—CTSB—intracranial aneurysm	0.00145	0.00182	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CTSS—intracranial aneurysm	0.00145	0.00182	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—NCF1—intracranial aneurysm	0.00145	0.00182	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—CTSS—intracranial aneurysm	0.00145	0.00182	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CTSS—intracranial aneurysm	0.00145	0.00182	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—CTSB—intracranial aneurysm	0.00145	0.00181	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—NCF1—intracranial aneurysm	0.00144	0.00181	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—NCF1—intracranial aneurysm	0.00144	0.0018	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—CTSS—intracranial aneurysm	0.00143	0.00179	CbGpPWpGaD
Bortezomib—CTSG—Metabolism of proteins—MMP2—intracranial aneurysm	0.00142	0.00178	CbGpPWpGaD
Bortezomib—CYP2C8—brain—intracranial aneurysm	0.00136	0.00676	CbGeAlD
Bortezomib—PSMA1—Metabolism—ASAH1—intracranial aneurysm	0.00135	0.00169	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—ASAH1—intracranial aneurysm	0.00135	0.00169	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—ASAH1—intracranial aneurysm	0.00134	0.00168	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CTSK—intracranial aneurysm	0.00134	0.00167	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CTSK—intracranial aneurysm	0.00134	0.00167	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—CTSK—intracranial aneurysm	0.00134	0.00167	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—CTSK—intracranial aneurysm	0.00132	0.00165	CbGpPWpGaD
Bortezomib—CYP1A1—brain—intracranial aneurysm	0.00126	0.00624	CbGeAlD
Bortezomib—PTGS1—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00125	0.00157	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.0012	0.00151	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CTSS—intracranial aneurysm	0.00116	0.00145	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CTSS—intracranial aneurysm	0.00116	0.00145	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CTSS—intracranial aneurysm	0.00115	0.00144	CbGpPWpGaD
Bortezomib—CYP2D6—cerebellum—intracranial aneurysm	0.00112	0.00555	CbGeAlD
Bortezomib—PSMB1—Adaptive Immune System—CTSB—intracranial aneurysm	0.00111	0.00138	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CTSB—intracranial aneurysm	0.00111	0.00138	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CTSB—intracranial aneurysm	0.00111	0.00138	CbGpPWpGaD
Bortezomib—PTGS1—brain—intracranial aneurysm	0.0011	0.00548	CbGeAlD
Bortezomib—PSMB5—Adaptive Immune System—NCF1—intracranial aneurysm	0.0011	0.00138	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—NCF1—intracranial aneurysm	0.0011	0.00138	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—NCF1—intracranial aneurysm	0.0011	0.00138	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—CTSB—intracranial aneurysm	0.00109	0.00136	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—NCF1—intracranial aneurysm	0.00108	0.00136	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CTSK—intracranial aneurysm	0.00107	0.00134	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CTSK—intracranial aneurysm	0.00106	0.00133	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CTSK—intracranial aneurysm	0.00106	0.00133	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—ASAH1—intracranial aneurysm	0.00103	0.00128	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—ASAH1—intracranial aneurysm	0.00103	0.00128	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—ASAH1—intracranial aneurysm	0.00103	0.00128	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—ASAH1—intracranial aneurysm	0.00101	0.00127	CbGpPWpGaD
Bortezomib—PSMA1—Disease—CST3—intracranial aneurysm	0.000935	0.00117	CbGpPWpGaD
Bortezomib—PSMD1—Disease—CST3—intracranial aneurysm	0.00093	0.00116	CbGpPWpGaD
Bortezomib—PSMD2—Disease—CST3—intracranial aneurysm	0.000926	0.00116	CbGpPWpGaD
Bortezomib—CYP2D6—brain—intracranial aneurysm	0.000907	0.0045	CbGeAlD
Bortezomib—PSMA1—Immune System—CTSB—intracranial aneurysm	0.000885	0.00111	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CTSB—intracranial aneurysm	0.000881	0.0011	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CTSS—intracranial aneurysm	0.00088	0.0011	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CTSS—intracranial aneurysm	0.00088	0.0011	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CTSS—intracranial aneurysm	0.00088	0.0011	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—NCF1—intracranial aneurysm	0.00088	0.0011	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CTSB—intracranial aneurysm	0.000876	0.0011	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—NCF1—intracranial aneurysm	0.000876	0.0011	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—NCF1—intracranial aneurysm	0.000872	0.00109	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CTSS—intracranial aneurysm	0.000868	0.00109	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000848	0.00106	CbGpPWpGaD
Bortezomib—PSMA1—Disease—NCF1—intracranial aneurysm	0.000813	0.00102	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CTSK—intracranial aneurysm	0.00081	0.00101	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CTSK—intracranial aneurysm	0.00081	0.00101	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CTSK—intracranial aneurysm	0.00081	0.00101	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—SLC25A16—intracranial aneurysm	0.000809	0.00101	CbGpPWpGaD
Bortezomib—PSMD1—Disease—NCF1—intracranial aneurysm	0.000809	0.00101	CbGpPWpGaD
Bortezomib—PSMD2—Disease—NCF1—intracranial aneurysm	0.000805	0.00101	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CTSK—intracranial aneurysm	0.000799	0.001	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000778	0.000974	CbGpPWpGaD
Bortezomib—PSMB5—Disease—CST3—intracranial aneurysm	0.000708	0.000887	CbGpPWpGaD
Bortezomib—PSMB1—Disease—CST3—intracranial aneurysm	0.000708	0.000887	CbGpPWpGaD
Bortezomib—PSMB2—Disease—CST3—intracranial aneurysm	0.000708	0.000887	CbGpPWpGaD
Bortezomib—PSMB8—Disease—CST3—intracranial aneurysm	0.000698	0.000875	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000694	0.000869	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CTSB—intracranial aneurysm	0.000671	0.00084	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CTSB—intracranial aneurysm	0.000671	0.00084	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CTSB—intracranial aneurysm	0.000671	0.00084	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—NCF1—intracranial aneurysm	0.000667	0.000835	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—NCF1—intracranial aneurysm	0.000667	0.000835	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—NCF1—intracranial aneurysm	0.000667	0.000835	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CTSB—intracranial aneurysm	0.000661	0.000828	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—NCF1—intracranial aneurysm	0.000658	0.000824	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000633	0.000792	CbGpPWpGaD
Bortezomib—PSMB5—Disease—NCF1—intracranial aneurysm	0.000616	0.000771	CbGpPWpGaD
Bortezomib—PSMB1—Disease—NCF1—intracranial aneurysm	0.000616	0.000771	CbGpPWpGaD
Bortezomib—PSMB2—Disease—NCF1—intracranial aneurysm	0.000616	0.000771	CbGpPWpGaD
Bortezomib—PSMB8—Disease—NCF1—intracranial aneurysm	0.000607	0.00076	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—AGER—intracranial aneurysm	0.000571	0.000715	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—SLC25A16—intracranial aneurysm	0.00057	0.000714	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—NCF1—intracranial aneurysm	0.000569	0.000713	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—AGER—intracranial aneurysm	0.000568	0.000712	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—NCF1—intracranial aneurysm	0.000566	0.000709	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—AGER—intracranial aneurysm	0.000566	0.000708	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—NCF1—intracranial aneurysm	0.000564	0.000706	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000541	0.000677	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000537	0.000673	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ASAH1—intracranial aneurysm	0.000536	0.000671	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000535	0.00067	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000532	0.000667	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—SLC25A16—intracranial aneurysm	0.000523	0.000655	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—SLC25A16—intracranial aneurysm	0.000467	0.000584	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—AGER—intracranial aneurysm	0.000433	0.000542	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—AGER—intracranial aneurysm	0.000433	0.000542	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—AGER—intracranial aneurysm	0.000433	0.000542	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NCF1—intracranial aneurysm	0.000431	0.00054	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NCF1—intracranial aneurysm	0.000431	0.00054	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NCF1—intracranial aneurysm	0.000431	0.00054	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—SLC25A16—intracranial aneurysm	0.000429	0.000537	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—AGER—intracranial aneurysm	0.000427	0.000534	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—SLC25A16—intracranial aneurysm	0.000425	0.000533	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NCF1—intracranial aneurysm	0.000425	0.000533	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—EDNRA—intracranial aneurysm	0.000407	0.00051	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000407	0.00051	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000407	0.00051	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—EDNRA—intracranial aneurysm	0.000402	0.000503	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ASAH1—intracranial aneurysm	0.000378	0.000473	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SLC25A16—intracranial aneurysm	0.000364	0.000455	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ASAH1—intracranial aneurysm	0.000346	0.000434	CbGpPWpGaD
Bortezomib—PSMA1—Disease—NOS3—intracranial aneurysm	0.000337	0.000422	CbGpPWpGaD
Bortezomib—PSMD1—Disease—NOS3—intracranial aneurysm	0.000335	0.00042	CbGpPWpGaD
Bortezomib—PSMD2—Disease—NOS3—intracranial aneurysm	0.000334	0.000418	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ASAH1—intracranial aneurysm	0.000309	0.000387	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ASAH1—intracranial aneurysm	0.000284	0.000356	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—NOS3—intracranial aneurysm	0.000282	0.000354	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ASAH1—intracranial aneurysm	0.000282	0.000353	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—NOS3—intracranial aneurysm	0.000281	0.000352	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.000281	0.000351	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—NOS3—intracranial aneurysm	0.00028	0.00035	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CCL2—intracranial aneurysm	0.000265	0.000332	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CCL2—intracranial aneurysm	0.000264	0.00033	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CCL2—intracranial aneurysm	0.000262	0.000329	CbGpPWpGaD
Bortezomib—PSMB5—Disease—NOS3—intracranial aneurysm	0.000255	0.00032	CbGpPWpGaD
Bortezomib—PSMB1—Disease—NOS3—intracranial aneurysm	0.000255	0.00032	CbGpPWpGaD
Bortezomib—PSMB2—Disease—NOS3—intracranial aneurysm	0.000255	0.00032	CbGpPWpGaD
Bortezomib—PSMB8—Disease—NOS3—intracranial aneurysm	0.000252	0.000315	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ASAH1—intracranial aneurysm	0.000241	0.000302	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—NOS3—intracranial aneurysm	0.000236	0.000296	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—NOS3—intracranial aneurysm	0.000235	0.000294	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—NOS3—intracranial aneurysm	0.000234	0.000293	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—NOS3—intracranial aneurysm	0.000214	0.000268	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—NOS3—intracranial aneurysm	0.000214	0.000268	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—NOS3—intracranial aneurysm	0.000214	0.000268	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—NOS3—intracranial aneurysm	0.000211	0.000264	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CCL2—intracranial aneurysm	0.000201	0.000251	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CCL2—intracranial aneurysm	0.000201	0.000251	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CCL2—intracranial aneurysm	0.000201	0.000251	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CCL2—intracranial aneurysm	0.000198	0.000248	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—MMP9—intracranial aneurysm	0.000189	0.000237	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—MMP9—intracranial aneurysm	0.000188	0.000236	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—MMP9—intracranial aneurysm	0.000188	0.000235	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	0.000186	0.000233	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NOS3—intracranial aneurysm	0.000179	0.000224	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NOS3—intracranial aneurysm	0.000179	0.000224	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NOS3—intracranial aneurysm	0.000179	0.000224	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NOS3—intracranial aneurysm	0.000176	0.000221	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MMP9—intracranial aneurysm	0.000144	0.00018	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MMP9—intracranial aneurysm	0.000144	0.00018	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MMP9—intracranial aneurysm	0.000144	0.00018	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MMP9—intracranial aneurysm	0.000142	0.000177	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—NOS3—intracranial aneurysm	0.000112	0.00014	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—NOS3—intracranial aneurysm	7.88e-05	9.87e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NOS3—intracranial aneurysm	7.23e-05	9.05e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NOS3—intracranial aneurysm	6.45e-05	8.08e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NOS3—intracranial aneurysm	5.93e-05	7.43e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NOS3—intracranial aneurysm	5.88e-05	7.36e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NOS3—intracranial aneurysm	5.02e-05	6.29e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NOS3—intracranial aneurysm	3.88e-05	4.86e-05	CbGpPWpGaD
